Found: 162
Select item for more details and to access through your institution.
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 2, p. 528, doi. 10.1002/jvc2.327
- By:
- Publication type:
- Article
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 2, p. 299, doi. 10.1007/s40257-024-00846-3
- By:
- Publication type:
- Article
Comment on 'Treatment of moderate-to-severe alopecia areata with baricitinib in preadolescent children with baricitinib': authors' reply.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 1, p. 136, doi. 10.1093/bjd/ljad276
- By:
- Publication type:
- Article
Rademikibart (CBP‐201), a next‐generation monoclonal antibody targeting human IL‐4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitis.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2614, doi. 10.1111/cts.13656
- By:
- Publication type:
- Article
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3209, doi. 10.1007/s13555-023-01063-2
- By:
- Publication type:
- Article
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 4, p. 392, doi. 10.1093/bjd/ljad182
- By:
- Publication type:
- Article
Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 10, p. 1117, doi. 10.1093/ced/llad203
- By:
- Publication type:
- Article
A male perspective on alopecia areata: are we doing enough?
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 10, p. 1190, doi. 10.1093/ced/llad208
- By:
- Publication type:
- Article
Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 10, p. 2357, doi. 10.1007/s13555-023-01010-1
- By:
- Publication type:
- Article
Topical application of a novel anti‐interleukin‐17A antibody fragment penetrates psoriatic skin: Results of a randomised, double‐blind, placebo‐controlled Phase Ib study.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 9, p. 1538, doi. 10.1111/exd.14861
- By:
- Publication type:
- Article
Australian dermatologists' prescribing behaviours for male androgenetic alopecia.
- Published in:
- Australasian Journal of Dermatology, 2023, v. 64, n. 3, p. 429, doi. 10.1111/ajd.14098
- By:
- Publication type:
- Article
Treatment of moderate-to-severe alopecia areata with baricitinib in preadolescent children.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 2, p. 248, doi. 10.1093/bjd/ljad118
- By:
- Publication type:
- Article
Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 4, p. 513, doi. 10.1007/s40257-023-00760-0
- By:
- Publication type:
- Article
Can brepocitinib be formulated into an effective topical therapy to treat mild-to-moderate chronic plaque psoriasis?
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 1, p. 9, doi. 10.1093/bjd/ljad157
- By:
- Publication type:
- Article
Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 6, p. 681, doi. 10.1093/ced/llad066
- By:
- Publication type:
- Article
Athena: Specialty Certificate Examination case for paediatrics and genetics.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 6, p. 710, doi. 10.1093/ced/llad058
- By:
- Publication type:
- Article
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 443, doi. 10.1007/s40257-023-00764-w
- By:
- Publication type:
- Article
Trichorrhexis nodosa improving with oral minoxidil: a case report.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 5, p. 554, doi. 10.1093/ced/llad019
- By:
- Publication type:
- Article
The alopecia areata donut sign. Evidence of synchronous hair growth in adult humans.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 4, p. e520, doi. 10.1111/jdv.18754
- By:
- Publication type:
- Article
Cross-specialty identification of the JAK1 inhibitor trial agent filgotinib as a potential therapy for alopecia areata.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 3, p. 442, doi. 10.1093/bjd/ljac103
- By:
- Publication type:
- Article
Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, shows efficacy in patients with active nonsegmental vitiligo and either a lighter or darker Fitzpatrick skin type: results from a phase 2b, randomized, doseranging study with an extension period.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. i3, doi. 10.1093/bjd/ljac106.004
- By:
- Publication type:
- Article
Upadacitinib treatment in patients with moderate to severe atopic dermatitis: A retrospective single‐centre Australian review of 14 patients post phase 3 clinical trial.
- Published in:
- Australasian Journal of Dermatology, 2023, v. 64, n. 1, p. 146, doi. 10.1111/ajd.13969
- By:
- Publication type:
- Article
Regrowth of hair in congenital triangular alopecia induced by sublingual minoxidil.
- Published in:
- Australasian Journal of Dermatology, 2023, v. 64, n. 1, p. 153, doi. 10.1111/ajd.13976
- By:
- Publication type:
- Article
Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 2, p. 218, doi. 10.1093/bjd/ljac059
- By:
- Publication type:
- Article
Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 2, p. 257, doi. 10.1111/ijd.16373
- By:
- Publication type:
- Article
Alopecia areata imitiert die frontale fibrosierende Alopezie.
- Published in:
- Kompass Dermatologie, 2023, v. 11, n. 1, p. 54, doi. 10.1159/000529198
- By:
- Publication type:
- Article
Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
- Published in:
- Clinical & Experimental Dermatology, 2022, v. 47, n. 11, p. 1951, doi. 10.1111/ced.15338
- By:
- Publication type:
- Article
Effective treatment of refractory lichen planus pemphigoides with a Janus kinase‐1/2 inhibitor.
- Published in:
- Clinical & Experimental Dermatology, 2022, v. 47, n. 11, p. 2040, doi. 10.1111/ced.15344
- By:
- Publication type:
- Article
Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 11, p. e416, doi. 10.1111/ijd.16316
- By:
- Publication type:
- Article
Clinical features and treatment outcomes of frontal fibrosing alopecia in men.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 10, p. e372, doi. 10.1111/ijd.16313
- By:
- Publication type:
- Article
A case of recurrent painful boils.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Treatment of dissecting cellulitis of the scalp with Tildrakizumab.
- Published in:
- Australasian Journal of Dermatology, 2022, v. 63, n. 3, p. 404, doi. 10.1111/ajd.13860
- By:
- Publication type:
- Article
Treatment of generalized granuloma annulare with tildrakizumab.
- Published in:
- Australasian Journal of Dermatology, 2022, v. 63, n. 3, p. e285, doi. 10.1111/ajd.13858
- By:
- Publication type:
- Article
Scalp reduction surgery does not reactivate frontal fibrosing alopecia: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15451
- By:
- Publication type:
- Article
Successful treatment of chronic severe alopecia areata with abrocitinib.
- Published in:
- Australasian Journal of Dermatology, 2022, v. 63, n. 2, p. 274, doi. 10.1111/ajd.13836
- By:
- Publication type:
- Article
Effective treatment of oral lichen planus with the JAK inhibitor baricitinib.
- Published in:
- Australasian Journal of Dermatology, 2022, v. 63, n. 2, p. 276, doi. 10.1111/ajd.13811
- By:
- Publication type:
- Article
Successful treatment of folliculitis decalvans with baricitinib: A case series.
- Published in:
- Australasian Journal of Dermatology, 2022, v. 63, n. 2, p. 279, doi. 10.1111/ajd.13786
- By:
- Publication type:
- Article
Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 4, p. 825, doi. 10.1007/s13555-022-00711-3
- By:
- Publication type:
- Article
Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape.
- Published in:
- Wound Practice & Research, 2022, v. 30, n. 1, p. 24, doi. 10.33235/wpr.30.1.24-33
- By:
- Publication type:
- Article
Hidradenitis suppurativa: an up-to-date review of clinical features, pathogenesis and therapeutic approaches.
- Published in:
- Wound Practice & Research, 2022, v. 30, n. 1, p. 40, doi. 10.33235/wpr.30.1.40-49
- By:
- Publication type:
- Article
Diffuse congenital hypotrichosis simplex with associated hair shaft fragility.
- Published in:
- Australasian Journal of Dermatology, 2022, v. 63, n. 1, p. e96, doi. 10.1111/ajd.13736
- By:
- Publication type:
- Article
Alopecias in humans: biology, pathomechanisms and emerging therapies.
- Published in:
- Veterinary Dermatology, 2021, v. 32, n. 6, p. 596, doi. 10.1111/vde.13014
- By:
- Publication type:
- Article
Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 9, p. 1135, doi. 10.1111/ijd.15657
- By:
- Publication type:
- Article
Effective treatment of folliculitis decalvans with cyclosporin: A case series.
- Published in:
- Australasian Journal of Dermatology, 2021, v. 62, n. 2, p. e345, doi. 10.1111/ajd.13532
- By:
- Publication type:
- Article
Effective treatment of disseminated superficial actinic porokeratosis using a novel topical cholesterol/simvastatin combination cream.
- Published in:
- Australasian Journal of Dermatology, 2021, v. 62, n. 1, p. 93, doi. 10.1111/ajd.13473
- By:
- Publication type:
- Article
Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study.
- Published in:
- Pediatric Dermatology, 2021, v. 38, n. 1, p. 103, doi. 10.1111/pde.14422
- By:
- Publication type:
- Article
Reversibility of alopecia caused by chronic cutaneous lupus erythematosus.
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 12, p. e437, doi. 10.1111/ijd.15148
- By:
- Publication type:
- Article
The Bairnsdale ulcer (Mycobacterium ulcerans) in an urban Victorian practice: A case series.
- Published in:
- Australasian Journal of Dermatology, 2020, v. 61, n. 4, p. 376, doi. 10.1111/ajd.13361
- By:
- Publication type:
- Article